| Autor: |
Buckner Tyler W., Daoud Nabil, Miles Moses, O'Neill Carrie, Watson Crystal, Recht Michael |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
The Journal of Haemophilia Practice, Vol 9, Iss 1, Pp 147-155 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2055-3390 |
| DOI: |
10.2478/jhp-2022-0020 |
| Popis: |
Haemophilia A and B are X-linked inherited bleeding disorders, resulting in the deficiency of clotting factor VIII and IX, respectively. Since the introduction of recombinant clotting factor concentrates in the early 1990s, the major safety concern for haemophilia therapy has been the development of inhibitory antibodies, or inhibitors. Over the recent past, new therapies for the treatment and prevention of bleeding have received regulatory approval or are under study. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
